Large conserved domains of low DNA methylation maintained by Dnmt3a.

TitleLarge conserved domains of low DNA methylation maintained by Dnmt3a.
Publication TypeJournal Article
Year of Publication2014
AuthorsJeong, M, Sun, D, Luo, M, Huang, Y, Challen, GA, Rodriguez, B, Zhang, X, Chavez, L, Wang, H, Hannah, R, Kim, S-B, Yang, L, Ko, M, Chen, R, Göttgens, B, Lee, J-S, Gunaratne, P, Godley, LA, Darlington, GJ, Rao, A, Li, W, Goodell, MA
JournalNat Genet
Volume46
Issue1
Pagination17-23
Date Published2014 Jan
ISSN1546-1718
Keywords5-Methylcytosine, Animals, Base Sequence, Conserved Sequence, CpG Islands, Cytosine, Databases, Genetic, DNA (Cytosine-5-)-Methyltransferases, DNA Methylation, DNA Methyltransferase 3A, Epigenesis, Genetic, Gene Expression Regulation, Hematopoietic Stem Cells, Histones, Humans, Leukemia, Male, Mice, Mice, Inbred C57BL, Mice, Mutant Strains
Abstract

Gains and losses in DNA methylation are prominent features of mammalian cell types. To gain insight into the mechanisms that promote shifts in DNA methylation and contribute to changes in cell fate, including malignant transformation, we performed genome-wide mapping of 5-methylcytosine and 5-hydroxymethylcytosine in purified mouse hematopoietic stem cells. We discovered extended regions of low methylation (canyons) that span conserved domains frequently containing transcription factors and are distinct from CpG islands and shores. About half of the genes in these methylation canyons are coated with repressive histone marks, whereas the remainder are covered by activating histone marks and are highly expressed in hematopoietic stem cells (HSCs). Canyon borders are demarked by 5-hydroxymethylcytosine and become eroded in the absence of DNA methyltransferase 3a (Dnmt3a). Genes dysregulated in human leukemias are enriched for canyon-associated genes. The new epigenetic landscape we describe may provide a mechanism for the regulation of hematopoiesis and may contribute to leukemia development.

DOI10.1038/ng.2836
Alternate JournalNat Genet
PubMed ID24270360
PubMed Central IDPMC3920905
Grant ListCA125123 / CA / NCI NIH HHS / United States
MC_PC_12009 / MRC_ / Medical Research Council / United Kingdom
079249 / WT_ / Wellcome Trust / United Kingdom
AI07495 / AI / NIAID NIH HHS / United States
DK092883 / DK / NIDDK NIH HHS / United States
R01 HD065812 / HD / NICHD NIH HHS / United States
DK084259 / DK / NIDDK NIH HHS / United States
G0900729/1 / NC3RS_ / National Centre for the Replacement, Refinement and Reduction of Animals in Research / United Kingdom
P50 CA126752 / CA / NCI NIH HHS / United States
P30 CA125123 / CA / NCI NIH HHS / United States
G0900951 / MRC_ / Medical Research Council / United Kingdom
R01 CA151535 / CA / NCI NIH HHS / United States
RC2 AG036562 / AG / NIA NIH HHS / United States
R01 HG007538 / HG / NHGRI NIH HHS / United States
100140 / WT_ / Wellcome Trust / United Kingdom
K99 DK084259 / DK / NIDDK NIH HHS / United States
R56 DK092883 / DK / NIDDK NIH HHS / United States
AG036562 / AG / NIA NIH HHS / United States
R01HG007538 / HG / NHGRI NIH HHS / United States
T32 AI007495 / AI / NIAID NIH HHS / United States
12765 / CRUK_ / Cancer Research UK / United Kingdom
CA151535 / CA / NCI NIH HHS / United States
CA126752 / CA / NCI NIH HHS / United States
R00 DK084259 / DK / NIDDK NIH HHS / United States
R01 DK092883 / DK / NIDDK NIH HHS / United States

Similar Publications